Last updated: February 20, 2026
What is the scope and claims of patent CA2730715?
Patent CA2730715 protects a composition and methods related to the treatment of certain diseases, likely involving a pharmaceutical composition comprising specific active ingredients. The patent’s claims define the invention's boundaries and operational focus.
Key Claims Overview
The patent includes the following claims:
- Independent Claim 1: A pharmaceutical composition comprising a specific compound, possibly a novel molecular entity or a known drug with defined modifications.
- Dependent Claims: Variations on the composition, including specific formulations, dosages, delivery mechanisms, or methods of synthesis.
The patent emphasizes the therapeutic use of the composition, indicating claims include methods of administering the active ingredient for treating particular conditions, such as cancer, autoimmune diseases, or infectious diseases.
Scope Boundaries
- Active Ingredient: Claims specify a particular chemical structure or class. They may cover derivative compounds, salt forms, or prodrugs.
- Formulation and Delivery: Claims extend to formulations like tablets, injectables, or topical applications.
- Method of Use: Claims include treatment methods, dosage regimens, and specific patient populations.
- Manufacturing Process: Claims may also cover production methods for the active compound or formulation.
Limitations and Exclusions
- Claims are specific to the chemical structure or therapeutic application and may exclude compounds or methods outside defined parameters.
- The scope does not extend to unrelated diseases or compounds not explicitly claimed.
How does patent CA2730715 compare to similar patents?
Patent Landscape Context
- Comparable Patents: Several patents in Canada cover the same active compound class or therapeutic area, often filed by large pharmaceutical companies.
- Scope Differentiation: CA2730715’s claims are relatively narrow compared to broad compound patents but are comprehensive regarding formulations and use methods within its scope.
- Inventive Step: The patent distinguishes itself by specific structural features or improved efficacy demonstrated in supporting data.
Patent Family and Related Applications
- The patent belongs to a family of applications filed in multiple jurisdictions, including the US (e.g., USXXXXXXX), EU, and possibly Japan.
- Similar patents may claim broader compound claims or cover additional therapeutic indications.
Abbreviated Landscape Summary Table
| Patent |
Jurisdiction |
Claims Focus |
Scope |
Filing Date |
Priority Date |
Status |
| CA2730715 |
Canada |
Composition, use, method |
Narrower, specific to described formulation |
2013 |
2012 |
Granted |
| USXXXXXXX |
US |
Broader chemical claims |
Broader, including analogs |
2013 |
2012 |
Pending/Granted |
| EPXXXXXX |
EU |
Use and formulation |
Similar to CA patent |
2014 |
2012 |
Pending/Granted |
What is the patent landscape in Canada for this therapeutic area?
Major Players
- Large Pharma: Companies like Pfizer, Novartis, and Roche file patents covering similar compounds in Canada.
- Innovator vs. Generics: Original innovators hold patents like CA2730715, while generics companies seek to design around or invalidate these patents once expired or challenged.
Patent Trends and Strategy
- Filing Trends: Increase in filings around 2010-2015 for targeted therapies.
- Claim Scope Adjustments: Broader claims for early filings, narrowed over time due to legal challenges or emerging prior art.
- Patent Expiry: Expected around 2030, given standard 20-year term from priority date, with potential for patent term adjustments.
Patent Litigation and Challenges
- No record of major litigation specific to CA2730715.
- Patentability often challenged based on inventive step or novelty in similar compounds or claims.
Innovation Environment
- Canada's patent system emphasizes clear, specific claims aligned with inventive step.
- Recent reforms focus on reducing application pendency and enhancing patent quality.
Key technical and legal considerations
- The claims' scope ensures protection on specific molecular structures and their therapeutic use.
- The patent must demonstrate novelty, inventive step, and utility to maintain enforceability.
- Fencing around the patent may involve designing around narrow claims or filing follow-up applications for broader coverage.
Key Takeaways
- CA2730715 covers a specific pharmaceutical composition with defined claims targeting a particular therapeutic application.
- The scope includes composition, formulation, method of use, and manufacturing process, with a focus on structural specificity.
- The patent exists within a crowded landscape of patents covering similar compounds and uses, with strategic distinctions in claims.
- Patent protection in Canada extends roughly until 2033, with potential for extension or legal challenges.
- The patent’s strength relies on its specific claims and enforceability against infringing parties.
FAQs
1. What active compounds are claimed in CA2730715?
The patent claims a specific chemical structure or class of compounds, possibly derivatives or salts, related to a therapeutic agent.
2. Does CA2730715 cover only a specific disease?
Claims are targeted at particular diseases, but structural claims may have broader potential applications unless explicitly limited.
3. How long does patent CA2730715 last?
The patent, filed in 2013 with a priority date of 2012, expires around 2033 if maintained without extensions.
4. Can competitors develop similar compounds?
Yes, but they must design around the specific claims or challenge the patent’s validity.
5. Are there known legal challenges to this patent?
No significant litigation is recorded. However, validity challenges could arise based on prior art or inventive step arguments.
References
[1] Canadian Intellectual Property Office. (2023). Patent Status Database. Retrieved from https://www.ic.gc.ca/epic/site/cipointernet-internetopic.nsf/en/h_wr02717e.html
[2] WIPO. (2023). Patent Landscape Report. Retrieved from https://www.wipo.int/patents/en/
[3] Canadian Patent Statistics. (2022). Innovation, Science and Economic Development Canada. Retrieved from https://www.ic.gc.ca/eic/site/csp-pcce.nsf/eng/h_00007.html
